A federal court has ruled in Apple's favor in the years-long fight against AliveCor, preventing a potential total import ban ...
The three disputed patents were found to be not patentable. You might have heard of Apple's patent dispute with medical ...
In 2021, AliveCor went to the ITC to accuse Apple of infringing on three of its patents with the Apple Watch’s heart rate monitoring features. In June 2022, the ITC reached an initial finding ...
At the end of 2023 and the start of 2024, Apple wasn’t able to sell either its Apple Watch Series 9 or its flagship Apple ...
The federal appeals court upheld the ruling invalidating the patents, and vacated the ITC's decision as a result, so there will be no Apple Watch import ban in the AliveCor case. In a statement to ...
March 7 - Apple (AAPL.O), opens new tab convinced a U.S. appeals court on Friday to uphold its win against medical device maker AliveCor in a patent dispute that could have led to an import ban on ...
A decision made Friday by the the US Court of Appeals for the Federal Circuit means that the Apple Watch will not face an import ban in U.S.
For the first time ever, global smartwatch shipments declined in 2024, with Apple experiencing its sharpest downturn yet.
U.S District Judge Jeffrey White said Friday that medical device and AI company AliveCor — the first to win the U.S. Food and Drug Administration's clearance for a medical-device accessory to the ...
securing a crucial win against AliveCor in a fight that could have led to an import ban on the Apple Watch. The U.S. Court of Appeals for the Federal Circuit today upheld the invalidation of ...
According to Counterpoint senior research analyst Anshika Jain, Apple Watch experienced a decline in its 10th year on the ...
There was a risk of history repeating itself, with another company — AliveCor — alleging that Apple had infringed patents related to heart-rate monitoring on certain models of Apple Watch.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results